MICRObiota on BILIOpancreatic malignant diseases [MICROBILIO]: A systematic review

Clinics - Tập 77 - Trang 100101 - 2022
Vitoria Carneiro de Mattos1, Fernanda Sayuri do Nascimento1, Milena Oliveira Suzuki1, João Victor Taba1, Leonardo Zumerkorn Pipek1, Walter Augusto Fabio Moraes1, Vitor Santos Cortez1, Márcia Saldanha Kubrusly2, Matheus Belloni Torsani1, Leandro Iuamoto3, Wu Tu Hsing3, Luiz Augusto Carneiro-D'Albuquerque4, Alberto Meyer4, Wellington Andraus4
1Faculdade de Medicina, Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil
2Department of Gastroenterology (LIM-37), Faculdade de Medicina, Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil
3Center of Acupuncture, Department of Orthopaedics and Traumatology, Faculdade de Medicina, Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil
4Department of Gastroenterology, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil

Tài liệu tham khảo

Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativa 2020: incidência de câncer no Brasil/Instituto Nacional de Câncer José Alencar Gomes da Silva. – Rio de Janeiro: INCA, 2019. Available at:https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/estimativa-2020-incidencia-de-cancer-no-brasil.pdfk. Access on 26th July 2020. Siegel, 2020, Cancer statistics, 2020, CA Cancer J Clin, 70, 7, 10.3322/caac.21590 2020 Ministério da Saúde. DATASUS. Available at: http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sim/cnv/obt10uf.def. Access on 07th May 2020. Bridgewater, 2016, Biliary tract cancer: epidemiology, radiotherapy, and molecular profiling, Am Soc Clin Oncol Educ Book, 35, e194, 10.1200/EDBK_160831 Torre, 2018, Worldwide burden of and trends in mortality from gallbladder and other biliary tract cancers, Clin Gastroenterol Hepatol, 16, 427, 10.1016/j.cgh.2017.08.017 Goggins, 2020, International Cancer of the Pancreas Screening (CAPS) consortium. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium, Gut, 69, 7, 10.1136/gutjnl-2019-319352 Khan, 2019, Cholangiocarcinoma: epidemiology and risk factors, Liver Int, 39, 19, 10.1111/liv.14095 Del Castillo, 2019, The microbiomes of pancreatic and duodenum tissue overlap and are highly subject specific but differ between pancreatic cancer and noncancer subjects, Cancer Epidemiol Biomarkers Prev, 28, 370, 10.1158/1055-9965.EPI-18-0542 Farrell, 2012, Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer, Gut, 61, 582, 10.1136/gutjnl-2011-300784 Chen, 2015, Cytotoxin-associated gene a-negative strains of helicobacter pylori as a potential risk factor of pancreatic cancer: a meta-analysis based on nested case-control studies, Pancreas, 44, 1340, 10.1097/MPA.0000000000000414 Schulte, 2015, Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis, Cancer Causes Control, 26, 1027, 10.1007/s10552-015-0595-3 Wei, 2019, The microbiota and microbiome in pancreatic cancer: more influential than expected, Mol Cancer, 18, 97, 10.1186/s12943-019-1008-0 Mima, 2017, The microbiome and hepatobiliary-pancreatic cancers, Cancer Lett, 402, 9, 10.1016/j.canlet.2017.05.001 Thomas, 2020, Microbiota in pancreatic health and disease: the next frontier in microbiome research, Nat Rev Gastroenterol Hepatol, 17, 53, 10.1038/s41575-019-0242-7 Zhang, 2020, Sphincter of Oddi laxity alters bile duct microbiota and contributes to the recurrence of choledocholithiasis, Ann Transl Med, 8, 1383, 10.21037/atm-20-3295 Moher, 2015, PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement, Syst Rev., 4, 1, 10.1186/2046-4053-4-1 University of Illinois at Chicago's Library of the Health Sciences at Peoria [Internet]. Evidence based medicine ‒ what is the PICO model? [cited 2020Sep23]. Available from: https://researchguides.uic.edu/c.php?g=252338&p=3954402. Ouzzani, 2016, Rayyan-a web and mobile app for systematic reviews, Syst Rev, 5, 210, 10.1186/s13643-016-0384-4 National Heart, Lung, and Blood Institute. Study Quality Assessment Tools. Available at https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. Access on 26th July 2020. Cochrane Methods Screening and Diagnostic Tests [Internet]. Handbook for DTA Reviews. [cited 2020Sep23]. Available from: http://methods.cochrane.org/sdt/handbook-dta-reviews. Fan, 2018, Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study, Gut, 67, 120, 10.1136/gutjnl-2016-312580 Torres, 2015, Characterization of the salivary microbiome in patients with pancreatic cancer, PeerJ, 3, e1373, 10.7717/peerj.1373 Ren, 2017, Gut microbial profile analysis by MiSeq sequencing of pancreatic carcinoma patients in China, Oncotarget, 8, 95176, 10.18632/oncotarget.18820 Chen, 2019, A Preliminary study of biliary microbiota in patients with bile duct stones or distal cholangiocarcinoma, Biomed Res Int, 2019 Riquelme, 2019, Tumor microbiome diversity and composition influence pancreatic cancer outcomes, Cell, 178, 795, 10.1016/j.cell.2019.07.008 Serra, 2018, Bactibilia in women affected with diseases of the biliary tract and pancreas. A STROBE guidelines-adherent cross-sectional study in Southern Italy, J Med Microbiol, 67, 1090, 10.1099/jmm.0.000787 Di Carlo, 2019, The microbiota of the bilio-pancreatic system: a cohort, STROBE-compliant study, Infect Drug Resist, 12, 1513, 10.2147/IDR.S200378 Vogtmann, 2020, Oral microbial community composition is associated with pancreatic cancer: a case-control study in Iran, Cancer Med, 9, 797, 10.1002/cam4.2660 Mei, 2018, Characterization of the duodenal bacterial microbiota in patients with pancreatic head cancer vs. healthy controls, Pancreatology, 18, 438, 10.1016/j.pan.2018.03.005 Half, 2019, Fecal microbiome signatures of pancreatic cancer patients, Sci Rep, 9, 16801, 10.1038/s41598-019-53041-4 Sun, 2020, Characterization of oral microbiome and exploration of potential biomarkers in patients with pancreatic cancer, Biomed Res Int, 2020, 10.1155/2020/4712498 Olson, 2017, The oral microbiota in patients with pancreatic cancer, patients with IPMNs, and controls: a pilot study, Cancer Causes Control, 28, 959, 10.1007/s10552-017-0933-8 Wei, 2020, Oral microbiome and pancreatic cancer, World J Gastroenterol, 26, 7679, 10.3748/wjg.v26.i48.7679 Kohi, 2020, Alterations in the duodenal fluid microbiome of patients with pancreatic cancer, Clin Gastroenterol Hepatol Clarridge, 2004, Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases, Clin Microbiol Rev, 17, 840, 10.1128/CMR.17.4.840-862.2004 Mazidi, 2016, Gut microbiome and metabolic syndrome, Diabetes Metab Syndr, 10, S150, 10.1016/j.dsx.2016.01.024 Jandhyala, 2015, Nageshwar Reddy D. Role of the normal gut microbiota, World J Gastroenterol, 21, 8787, 10.3748/wjg.v21.i29.8787 Frank, 2007, Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases, Proc Natl Acad Sci U S A, 104, 13780, 10.1073/pnas.0706625104 Hollister, 2014, Compositional and functional features of the gastrointestinal microbiome and their effects on human health, Gastroenterology, 146, 1449, 10.1053/j.gastro.2014.01.052 Ewaschuk, 2006, Probiotics and prebiotics in chronic inflammatory bowel diseases, World J Gastroenterol, 12, 5941, 10.3748/wjg.v12.i37.5941 Nascimento, 2020, Analysis of biliary MICRObiota in hepatoBILIOpancreatic diseases compared to healthy people [MICROBILIO]: Study protocol, PLoS One, 15, 10.1371/journal.pone.0242553